METOCLOPRAMIDE DEMOGEN (Demogen Australia Pty Ltd trading as DEMOGEN Pharmaceuticals)

Adults (20 years and over)

• Relief of nausea and vomiting associated with migraine, cancer therapy (chemotherapy orradiation), malignant disease, labour, infectious disease and uraemia
• Control of post-operative vomiting
• Assist in small bowel intubation

Metoclopramide is of little benefit for the prevention or treatment of motion sickness.

Young Adults and Children (over 1 year of age)

Metoclopramide should be restricted to the following conditions and only used as second line therapy, when used to treat children and young adults under 20 years of age because of the risk of adverse effects:

• Severe intractable vomiting of known cause
• Vomiting associated with radiation therapy or intolerance to cytotoxic drugs
• Assist in small bowel intubation